Covance Expands Global Biologics Capabilities

Mar 25, 2014
By Applied Clinical Trials Editors

Covance announced it is expanding its large molecule bioanalytical space co-located with Covance’s central laboratory facility in Indianapolis, IN to grow its global biologics capabilities. The expansion, which is planned to open during the second half of 2014, is doubling the company’s large molecule capacity. With this expansion, Covance expects to add 100 new positions over the next five years. This investment will enable Covance to further leverage its small and large molecule bioanalytical expertise while providing scientific, logistic, and regulatory synergies for clients.

Read the full release here.

lorem ipsum